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Abstract: It has been demonstrated that, in addition to genomic RNA, sgmRNA is able  
to serve as a template for the synthesis of the negative-strand [(−)-strand] complement. 
However, the cis-acting elements on the positive-strand [(+)-strand] sgmRNA required for 
(−)-strand sgmRNA synthesis have not yet been systematically identified. In this study, we 
employed real-time quantitative reverse transcription polymerase chain reaction to analyze 
the cis-acting elements on bovine coronavirus (BCoV) sgmRNA 7 required for the synthesis 
of its (−)-strand counterpart by deletion mutagenesis. The major findings are as follows.  
(1) Deletion of the 5'-terminal leader sequence on sgmRNA 7 decreased the synthesis of 
the (−)-strand sgmRNA complement. (2) Deletions of the 3' untranslated region (UTR) 
bulged stem-loop showed no effect on (−)-strand sgmRNA synthesis; however, deletion  
of the 3' UTR pseudoknot decreased the yield of (−)-strand sgmRNA. (3) Nucleotides  
positioned from −15 to −34 of the sgmRNA 7 3'-terminal region are required for efficient  
(−)-strand sgmRNA synthesis. (4) Nucleotide species at the 3'-most position (−1) of sgmRNA 
7 is correlated to the efficiency of (−)-strand sgmRNA synthesis. These results together 
suggest, in principle, that the 5'- and 3'-terminal sequences on sgmRNA 7 harbor cis-acting 
elements are critical for efficient (−)-strand sgmRNA synthesis in BCoV. 








During coronavirus replication, in addition to genomic RNA, a 3' coterminal nested set of subgenomic 
mRNAs (sgmRNAs), which are also 5' coterminal with the leader sequence of the genome, are 
synthesized via discontinuous transcription [1–4]. A mechanism by which sgmRNA acquires the leader 
sequence during negative-strand [(−)-strand)] synthesis using the positive-strand [(+)-strand] genomic 
RNA as a template has gained favor to explain this discontinuous step [5–12]. It has been demonstrated 
that both (−)- and (+)-strand sgmRNAs are present in coronavicus-infected cells [8]. Moreover, the  
65–90-nt-long antileader sequence (depending on the species) on the (−)-strand sgmRNA has been 
proposed to be a promoter for the synthesis of its (+)-strand counterpart. It is therefore postulated  
that sgmRNA could be a replicon during coronavirus replication. However, no accumulation of the 
reporter-containing sgmRNA was found under the experimental condition in which the reporter-containing 
sgmRNA was transfected into helper-virus infected cells, suggesting that sgmRNA is not a replicon [13]. 
Regardless, using (+)-strand sgmRNA rather than (+)-strand genomic RNA as the template, it has been 
demonstrated that (−)-strand sgmRNA was synthesized and that smaller sgmRNA can also be produced 
if the sgmRNA template carried a transcription signal, suggesting that coronavirus is able to amplify 
sgmRNA via a mechanism other than replication [14]. Coronavirus sgmRNAs synthesized by this 
alternative mechanism may relieve pressure on the large genome, enhance disease development through 
the rapid amplification of virulence factors encoded by a large number of sgmRNAs, and contribute  
to the survival of the largest known viral RNA genome via sgmRNA-assisted recombination with the 
genome [15–21]. 
Due to the limited number of (−)-strand viral RNAs present in cells and insufficient methods for 
detecting and quantitating the synthesis of (−)-strand coronaviral RNA, little is known regarding the 
mechanism of how coronaviral (−)-strand RNA is generated [8]. For bovine coronavirus (BCoV), 
BCoV defective interfering (DI) RNA, a surrogate for the BCoV genome, has been used as a 
minireplicon for the study of cis-acting elements required for replication [interpreted as (+)-strand 
synthesis] [22–31]. Nonetheless, the identification of cis-acting elements required for (−)-strand BCoV 
DI RNA synthesis has been hampered due to inadequate methods for the detection of (−)-strand BCoV 
DI RNA. To overcome the technical problems, Wu and Brian have developed a head-to-tail ligation 
method and reverse transcription polymerase chain reaction (RT-PCR) to detect (−)-strand BCoV DI 
RNA and sgmRNA, demonstrating that both the BCoV DI RNA and sgmRNA (−) strands can be 
generated from their (+)-strand counterparts [14]. Accordingly, this may constitute a useful system for 
determining the cis-acting elements for the synthesis of BCoV (−)-strand DI RNA and sgmRNA [32]. 
In BCoV DI RNA, there are two putative stem-loop (SL) structures in the leader sequence which 
are part of the genome 5' UTR and required for the replication of BCoV DI RNA [13]. Downstream of 
the leader sequence in BCoV DI RNA is the 5'-proximal 421-nts region which includes 5' UTR and 
nsp1 coding sequence and is missing in sgmRNA 7, which corresponds to the sgmRNA encoding N 
protein. This region contains other higher-order RNA elements which have been determined to be the 
cis-acting elements important for the replication [22,27,28,33]. In the 3' UTR, two higher-order structures 
in the upstream region have been identified as cis-acting RNA elements essential for coronavirus 
replication, including a bulged stem-loop (BSL) [34,35] and a hairpin-type pseudoknot (PK) [31]. 
Further downstream of the 3' UTR is a hypervariable region (HVR) that has been demonstrated to be 
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nonessential for RNA synthesis but does play a pivotal role in pathogenesis [36]. In coronaviruses, 
sgmRNA is structurally coterminal with the genome by the 5' leader sequence and the 3' UTR [1]. Because 
BCoV sgmRNA can serve as a template for the synthesis of its (−)-strand counterpart [14], we speculate 
that these cis-acting RNA structures on sgmRNA may also be involved in the process of (−)-strand 
RNA synthesis. In the present work, we identified the cis-acting elements on the (+)-strand sgmRNA 
that are required for (−)-strand sgmRNA synthesis using real-time quantitative reverse transcription 
polymerase chain reaction (RT-qPCR). Our findings indicate that the terminal sequences on the sgmRNA 
5' and 3' UTRs are critical elements for efficient (−)-strand sgmRNA synthesis. 
2. Materials and Methods 
2.1. Viruses and Cells 
A DI RNA-free stock of the Mebus strain of BCoV [GenBank accession no. U00735] at  
3 × 107 PFU/mL was used as a helper virus in the human rectal tumor (HRT)-18 cell line, as described 
previously [37,38]. 
2.2. Plasmid Constructs 
Construction of pBM25A in which the 288-nt 3' UTR of BCoV-Mebus DI RNA in pDrep1  
was replaced with the 301-nt 3' UTR and 25-nt poly(A) tail of MHV-A59 has been described [32].  
To construct psBM25A, pNrep1, which encodes BCoV sgmRNA 7 [13], was digested with NgoMIV  
and XbaI, and the digested fragment containing the sgmRNA 7 5' leader sequence was cloned  
into NgoMIV and XbaI-linearized pBM25A, creating BCoV sgmRNA 7 with the 301-nt 3' UTR and  
25-nt poly(A) tail of MHV-A59. A previously described overlap PCR mutagenesis procedure was  
used to construct sNL in which the leader sequence of sBM25A was deleted [5]: oligonucleotides 
pGEMNDEI(−) and sNL(+) and psBM25A DNA were used in the first PCR; oligonucleotides sNL(−) 
and RYN(+) and psBM25A DNA were used in the second PCR; and oligonucleotides pGEMNDEI(−) 
and RYN(+) and the products of the first two reactions were used in a third PCR to generate a 883-nt 
product that was cloned into the TOPO XL vector (Invitrogen). From this, a 462-nt fragment obtained 
by digestion with NgoMIV and XbaI was cloned into NgoMIV and XbaI-linearized psBM25A to produce 
psNL. Constructs of psΔSL1 and psΔSL2 in which stem-loop I and stem-loop II, respectively, was 
deleted were similarly generated except for the corresponding oligonucleotides used in the first and  
second reactions, as described in Table S1. Construct psΔB (deletion of 3' UTR bulged stem-loop) was 
produced following a previously described overlap PCR mutagenesis procedure but with oligonucleotides 
TGEV 7(−) and sΔB (+) and pBM25A DNA in the first PCR, oligonucleotides sΔB (−) and DI 
reverse(+) and pBM25A DNA in the second PCR, and oligonucleotides TGEV 7(−) and DI reverse(+) 
and the products of the first two reactions in a third PCR, generating a 1203-nt product that was cloned 
into the TOPO XL vector (Invitrogen). From this, a 756-nt fragment obtained by digestion with SpeI 
and MluI was cloned into SpeI and MluI-linearized psBM25A to produce the mutant psΔB. Constructs 
psΔP (deletion of 3' UTR pseudoknot), ps3'Δ55 (deletion of 3'-termianl 55 nts), psΔ3'15 (deletion of 
3'-termianl 15 nts), psΔ3'55–40 (deletion of nts from −40 to −55), psΔ3'55–35 (deletion of nts from 
−35 to −55), psΔ3'55–30 (deletion of nts from −30 to −55), psΔ3'30–15 (deletion of nts from −15 to 
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−30), psgmA’ (substitution of the 3'-most nt with adenine), psgmG’ (substitution of the 3'-most nt with 
guanine), and psgmU’ (substitution of the 3'-most nt with uracil) were similarly constructed except the 
corresponding oligonucleotides (Table S1) used in the first and second reactions. 
2.3. RT-PCR for Detecting (−)-Strand RNA Products 
MluI-linearized pBM25A and psBM25A were transcribed in vitro with RiboMAx T7 kit (Promega, 
Madison, WI, USA) in a total reaction volume of 50 μL. The reaction was performed at 37 °C for 90 
min, treated with 5 μL DNase, and chromatographed through a Biospin 6 column (Bio-Rad, Hercules, 
CA, USA). For transfection, 3 µg of transcript, which was quantitated by denaturing gel 
electrophoresis, was transfected into HRT-18 cells with lipofectin (Invitrogen, Carlsbad, CA, USA) in 
35-mm dishes at ~80% confluency (~8 × 105 cells/dish), which were infected with BCoV at a 
multiplicity of infection of five PFU per cell 2 h prior to transfection [13] and virus within the 
transfected cells was referred to as virus passage 0 (VP0). To detect (−)-strand RNA, the total cellular 
RNA was extracted with TRIzol (Invitrogen) at 8 h posttransfection (hpt). Head-to-tail ligation of viral 
RNA and RT-PCR for detecting (−)-strand RNA have been described previously [14,39]. For this, 10 µg 
of extracted RNA was treated with 10 U (in 1 µL) of tobacco acid pyrophosphatase (Epicentre, 
Madison, WI, USA) in 25 µL of water and 3 µL of 10× buffer to remove the 5' capped end of the 
RNA. After phenol-chloroform extraction, the decapped RNA in 25 µL of water was heat-denatured at 
95 °C for 5 min and then quick-cooled for 1 min. Then, 3 µL of 10× ligase buffer and 2U (in 2 µL) of 
T4 RNA ligase I (New England Biolabs, Ipswich, MA, USA) were added, and the mixture was 
incubated for 16 h at 16 °C. The ligated RNA was phenol-chloroform extracted and quantitated,  
and 1 µg of ligated RNA was used for the RT reaction to detect (−)-strand BM25A and sBM25A. 
Oligonucleotide MHV3'UTR3(−), which anneals at nts 89–112 from the poly(U) tail on the (−) strand 
of the MHV-A59 3' UTR, was used to synthesize cDNA with SuperScript III reverse transcriptase 
(Invitrogen). A 5-µL aliquot of this reaction was used in a 50-µL PCR with AccuPrime Tag DNA 
polymerase (Invitrogen) and oligonucleotides MHV3'UTR6(−), which anneals at nts 64–85 from the 
poly(U) tail on the (−) strand of the MHV-A59 3' UTR, and BCV23-40(+), which anneals at nts 23–40 
on the (+)-strand leader of BCV. The mixture was heated to 94 °C for 2 min and then subjected to 50 
cycles of 30 s at 94 °C, 30 s at 60 °C, and 30 s at 72 °C. The resulting RT-PCR products of ~150-base 
pair (bp) were directly sequenced. To detect the (−)-strand RNA without head-to-tail ligation step, 1 
µg of RNA was used for RT-PCR reaction with oligonucleotides MHV3'UTR-DR(−) (for RT), which 
binds to nts 140–160 from the poly(U) tail in the (−) strand of the MHV-A59 3' UTR and MHV3UTR-
DR(+), which binds to nts 56–73 from the poly(U) tail in the (−) strand of the MHV-A59 3' UTR. The 
mixture was heated to 94 °C for 2 min and then subjected to 25 cycles of 30 s at 94 °C, 30 s at 60 °C, 
and 30 s at 72 °C. 
2.4. Quantitation of (−)-Strand sgmRNA Synthesis by RT-qPCR 
To assess the efficiency of (−)-strand sgmRNA synthesis from wt sBM25A and the mutants  
except sNL, sΔSL1 and sΔSL2, 1 µg of decapped and ligated RNA collected from BCoV-infected  
sgmRNA-transfected HRT-18 cells at 8 hpt was used in an RT reaction with oligonucleotide 
MHV3'UTR3(−) and SuperScript III reverse transcriptase (Invitrogen). TaqMan probe-5 (Table S1) 
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used for RT-qPCR were designed by the Primer Express computer program (Applied Biosystems, Foster 
City, CA, USA). The real-time PCR amplification was performed in a LightCycler® 480 instrument 
(Roche Applied Science, Indianapolis, IN, USA) using MHV3'UTR6(−) and BCV23-40(+) primers, 
and TaqMan®Universal PCR Master Mix (Applied Biosystems) according to the manufacturer’s 
recommendations. To assess the efficiency of (−)-strand sgmRNA synthesis from wt sBM25A and the 
mutants sNL, sΔSL1 and sΔSL2, 1 µg of RNA with decapping and head-to-tail ligation was used for RT 
reaction with oligonucleotide MHV3'UTR-DR(−) to synthesize cDNA with SuperScript III reverse 
transcriptase (Invitrogen). TaqMan®Universal PCR Master Mix (Applied Biosystems) with TaqMan 
probe-3 and primers MHV3UTR-DR(-) and BCVN(+) was used for RT-qPCR. To assess the synthesis of 
(−)-strand RNA from RNA samples without decapping and head-to-tail ligation, 1 µg of RNA was used for 
RT reaction with oligonucleotide MHV3'UTR-DR(−) to synthesize cDNA with SuperScript III reverse 
transcriptase (Invitrogen). TaqMan®Universal PCR Master Mix (Applied Biosystems) with TaqMan 
probe-3 and primers MHV3UTR-DR(−) and MHV3UTR-DR(+) (Table S1), which binds to nts 56–73 
from the poly(U) tail in the (−) strand of the MHV-A59 3' UTR, was used for RT-qPCR. In either of 
the experiments, dilutions of plasmids containing the same gene as the detected (−)-strand RNA were 
always run in parallel with the quantitated cDNA for use as standard curves (the dilutions ranged from 
108–10 copies of each plasmid). The efficiency of (−)-strand RNA synthesis was normalized with the 
levels of internal controls, including 18S rRNA (with primers 18SrRNA(−) and 18SrRNA(+)), (+)-
strand reporter-containing sgmRNA (with primers MHV3UTR-DR(−) and MHV3UTR-DR(+)) and 
helper virus M sgmRNA (with primers leader20(−) and M(+)) extracted at 8 hpt (VP0). The reactions 
were performed as an initial pre-incubation at 95 °C for 5 min, followed by 35 amplification cycles  
of 95 °C for 15 s and 60 °C for 60 s. 
2.5. Northern Blot Assay for DI RNA Replication 
A Northern blot assay was performed as described previously [11,13]. Briefly, HRT-18 cells in  
35-mm dishes at ~80% confluency (~8 × 105 cells/dish) were infected with BCoV at a multiplicity of 
infection of five PFU per cell. Two hours post-infection (hpi), 3 µg of transcript was transfected into 
the HRT-18 cells. To detect the replication of BCoV DI RNA and sgmRNAs, the supernatant was 
collected at 48 hpt and then used to infect fresh HRT-18 cells (virus passage 1, VP1). Ten µg of TRIzol-
extracted total cellular RNA at 48 hpi of VP1 was used for formaldehyde-agarose gel electrophoresis. 
To detect 18S rRNA, reporter-containing sgmRNA, and M sgmRNA, 10 µg of TRIzol-extracted total 
cellular RNA at 8 hpt (VP0) was used for formaldehyde-agarose gel electrophoresis. RNA was then 
transferred from the gel to Nytran membranes by vacuum blotting. The blots were probed with 
digoxigenin (DIG)-ddUTP labeled (DIG Oligonucleotide 3'-End Labeling kit; Roche Molecular 
Biochemicals) oligonucleotides: TGEV 8(+) (for reporter-containing BM25A, sBM25A, and 
sgmRNA), BCVN(+) (for M sgmRNA), and 18SrRNA(+) (for 18S rRNA). The detected RNA was 
visualized according to the procedure of the manufacturer. 
2.6. Statistical Analyses 
Statistical calculations were performed using GraphPad Prism v2.01 [40]. p values were determined 
with paired t test for RT-qPCR data. 




3.1. The (−)-Strand Synthesis from sgmRNA 7 Is ~2-Fold less than that from BCoV DI RNA,  
a Surrogate for BCoV Genome 
To study coronavirus replication, an ~ 2.2 kb BCoV DI RNA has been employed as a surrogate for 
the ~30 kb BCoV genome (Figure 1A, upper panel) [10,11,13,22,23,27–29,31,33]. In DI RNA-transfected 
BCoV-infected cells at 24 hpi of VP1, however, there are only an estimated ~5 molecules of BCoV DI 
RNA (−) strand per cell [11,41]. Therefore, to overcome (1) the detection problem due to the low copy 
number of (−)-strand BCoV DI RNA in infected cells and (2) the false positive results of (−)-strand DI 
RNA detection caused by copy-back (−)-strand DI RNA transcripts generated by T7 RNA polymerase 
using plasmid DNA as a template [42], a head-to-tail ligation method and reverse transcription 
polymerase chain reaction (RT-PCR) (Figure 1B) have been developed to detect and quantitate the 
synthesis of (−)-strand BCoV DI RNA [14,32,39]. With this method, it has been demonstrated that  
both BCoV DI RNA and BCoV sgmRNA 7 can function as the template for the synthesis of their  
(−)-strand copies [14], even though sgmRNA 7 lacks the 5'-proximal 421 nts in comparison to the 
genome surrogate BCoV DI RNA. The relative efficiency of (−)-strand synthesis between the two RNA 
species, however, has not been previously described. Thus, to assess the efficiency of (−)-strand RNA 
synthesis between the two species and then to determine the requirement of the 5'-proximal 421 nts  
for the synthesis of (−)-strand viral RNA, constructs BM25A, which represents BCoV DI RNA, and 
sBM25A, which represents sgmRNA 7 (Figure 1A, lower panel), were generated. The BCoV 3’ UTR 
from either of the constructs was replaced with the MHV 3' UTR to distinguish them from the helper 
virus during detection. The transcripts of BM25A and sBM25A were separately transfected into 
BCoV-infected HRT-18 cells and cellular RNA was extracted at 8 hpt. The extracted RNA was decapped, 
head-to-tail ligated, and subjected to RT-PCR with primers MHV3'UTR6(−) and BCV23-40(+)  
(Figure 1B). An ~150-bp RT-PCR product was detected from the BCoV-infected cells transfected with 
BM25A or sBM25A (Figure 1C, lanes 2–3) but not from the mock-infected cells, BCoV-infected  
cells, transfected mock-infected cells, or in control reactions with mixed components of infected cell 
RNA and input BM25A or sBM25A (Figure 1C, lanes 4–9). Taken together, these results demonstrated  
that the RT-PCR products are specifically from putative viral polymerase-generated (−)-strand RNA. 
Furthermore, it has been shown that the input DI RNA and coronavirus genome may undergo 
recombination under certain selection pressure [15,16,43]. Therefore, the detected reporter-containing  
(−)-strand DI RNA or sgmRNA may be derived from a recombinant molecule containing the 
coronavirus genome and reporter-containing DI RNA or sgmRNA genes. To ensure that the detected  
(−)-strand RNA was specifically from reporter-containing BM25A or sBM25A rather than from  
a recombinant molecule, RT-PCR using primers that anneal to the reporter sequence in BM25A or 
sBM25A (for RT) and the M protein gene in the BCoV genome was performed to test for a potential 
recombinant molecule generated during infection [14]. No RT-PCR product was observed (Figure 1C, 
lanes 12–13), thus excluding the possibility of the detected (−)-strand RNA species being synthesized 
from a recombinant. Note that a recombinant DNA of 1639 bp (Figure 1C, lane 14) was produced  
to serve as a size marker [14,32,44] for a potential RT-PCR product in Figure 1C, lanes 12–13. To 
measure the efficiency of (−)-strand RNA synthesis from BM25A and sBM25A, RT-qPCR was performed 
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with 18S rRNA, input (+)-strand BM25A, or sBM25A and M sgmRNA of helper virus BCoV as 
internal controls (Figure 1D, left panel). Besides, to ensure that the (−)-strand RNA was synthesized 
under the similar experimental conditions, the level of reporter-containing (+)-strand BM25A or 
sBM25A, 18S rRNA, and sgmRNAs of helper virus BCoV at 8 hpt (VP0) was also determined with 
Northern blot assay (Figure 1D, right panel). As shown in Figure 1D (left panel), the efficiency of  
(−)-strand RNA synthesis was ~2-fold less from sBM25A than from BM25A (56% vs. 100%) under 
the similar experimental conditions. 
Figure 1. Comparison of the efficiency of the (−)-strand RNA synthesis between sgmRNA 
7 and BCoV DI RNA with the strategy of head-to-tail ligation. (A) Upper panel: schematic 
diagram depicting the BCoV genome and BCoV DI RNA. Lower panel: constructs 
BM25A and sBM25Awith the 3' UTR of both constructs replaced with the MHV 3' UTR. 
(B) Strategy for detection of (−)-strand sgmRNA with head-to-tail ligation. (C) RT-PCR 
product synthesized with the strategy described in Figure 1B. Lane 2, BM25A-transfected 
BCoV-infected cells; lane 3, sBM25A-transfected BCoV-infected cells; lane 4, mock-infected 
cells; lane 5, BCoV-infected and mock-transfected cells; lane 6, BM25A-transfected  
mock-infected cells; lane 7, sBM25A-transfected mock-infected cells; lane 8, a mixture of 
BCoV-infected cellular RNA extracted at 8 hpt and 200 ng of BM25A transcript; lane 9, a 
mixture of BCoV-infected cellular RNA extracted at 8 hpt and 200 ng of sBM25A transcript. 
RT-PCR was used to detect the potential recombination between the BCoV genome and 
BM25A (lane 12) or sBM25A (lane 13). A recombinant DNA of 1639 bp was produced to 
serve as a size marker (lane 14). M (lanes 1, 10 and 11), ds DNA size markers in nt pairs. 
(D) Left panel: the relative efficiency of (−)-strand RNA synthesis from constructs BM25A 
and sBM25A, as measured by RT-qPCR. Control A: total cellular RNA from mock-infected 
cells. Control B: total cellular RNA from BCoV-infected cells. Control C: total cellular 
RNA from sBM25A-transfected mock-infected cells. Control D: a mixture of BCoV-infected 
cellular RNA extracted at 8 hpt and 200 ng of BM25A transcript. Right panel: measurements 
of reporter-containing RNA (BM25A and sBM25A), 18S rRNA and BCoV sgmRNAs at 8 hpt 
(VP0) by Northern blot assay. The values (D) represent the mean ± SD of three individual 
experiments. *** p < 0.001. 
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Considering that the inefficient head-to-tail ligation may decrease the numbers of (−)-strand RNA 
species to be quantitated and thus may affect the subsequent interpretation of the results, RT-qPCR 
was also performed using RNA without ligation reaction with primers annealing to the hypervariable 
region of MHV 3' UTR. Although the false positive results of (−)-strand RNA detection caused  
by copy-back (−)-transcripts generated by T7 RNA polymerase may occur, the levels of copy-back 
molecules determined by RT-qPCR from uninfected cells transfected with transcripts can be used as 
the background levels of (−)-strand RNA for BM25A and sBM25A. The relative quantitation of (−)-strand 
RNA synthesis from BM25A and sBM25A compared to the background levels would suggest that the 
increase of the (−)-strand RNA synthesis is due to the activity of viral RNA-dependent RNA polymerase. 
As shown in Figure S1A, 1 µg of RNA without decapping and head-to-tail ligation was used for RT-PCR 
with primers MHV3UTR-DR(−) and MHV3UTR-DR(+), both of which bind to the hypervariable 
region of MHV 3' UTR. A ~100-bp RT-PCR product was detected from the BCoV-infected cells 
transfected with BM25A or sBM25A (lanes 2–3) but not from the mock-infected cells (lane 4) and 
BCoV-infected cells (lane 5). The ~100-bp RT-PCR product was also detected from uninfected cells 
transfected with BM25A or sBM25A (lanes 6–7), suggesting the RT-PCR product was caused by 
copy-back (−)-transcripts generated by T7 RNA polymerase. To measure the relative efficiency of  
(−)-strand RNA synthesis from BM25A and sBM25A, RT-qPCR was performed without the ligation 
of RNA. As shown in Figure S1B, the efficiency of the (−)-strand RNA synthesis from sBM25A was 
also ~2-fold less than that from BM25A (~60% of BM25A), confirming the previous results in which 
RNA samples were head-to-tail ligated prior to RT-qPCR. Taken together, these results suggest that 
the (−)-strand synthesis from sgmRNA 7 (sBM25A) is ~2-fold less than that from BCoV DI RNA 
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(BM25A), a surrogate for BCoV genome, and thus the 5'-proximal 421-nt sequence is required for 
optimal (−)-strand RNA synthesis in BCoV. 
3.2. Screening for cis-Acting Elements in the 5' and 3' UTRs Required for (−)-Strand  
sgmRNA 7 Synthesis 
Structurally, sgmRNAs and genomic RNA in BCoV share common features at the termini, 
including a 5' leader sequence and 3' UTR. In addition to the leader sequence [13] within the 5' UTR, 
the bulged stem-loop [34,35] and the hairpin-type pseudoknot [31] within the 3' UTR have been 
demonstrated to be cis-acting elements required for coronavirus replication. Furthermore, the 3'-terminal 
55-nt sequence has been shown to be critical for synthesis of (−)-strand MHV DI RNA [26]. However, 
these structures on (+)-strand sgmRNA have not been previously shown to be required for (−)-strand 
sgmRNA synthesis in BCoV. Thus, a series of sgmRNA mutants were constructed to examine the 
requirement of these RNA elements on (+)-strand sgmRNA for (−)-strand sgmRNA synthesis, including 
deletions of the leader sequence (sNL), bulged stem-loop (sΔB), pseudoknot (sΔP), and 3'-terminal  
55 nts (s3'Δ55) (Figure 2A). As the hypervariable region is not conserved among coronaviruses and 
has been shown to be nonessential for coronavirus replication [36], this region was not tested in this 
study. Transcripts of each mutant were separately transfected into BCoV-infected HRT-18 cells, and 
cellular RNA was extracted at 8 hpt and subjected to RT-qPCR. To determine the efficiency of (−)-strand 
synthesis from leader-deleted construct sNL (Figure 2A), 1 µg of RNA with head-to-tail ligation was 
used for RT-qPCR (Figure 2B, left panel) with primers MHV3UTR-DR(−) and BCVN(+) because the 
primer BCV23-40(+) used in the above-described studies (Figure 1D) cannot anneal to the (−) strand 
of sNL. Besides, 1 µg of RNA without head-to-tail ligation was also used for RT-qPCR (Figure 2B, 
right panel) with primers MHV3UTR-DR(−) and MHV3UTR-DR(+). As shown in Figure 2B, the 
synthesis of (−)-strand sgmRNA from the leader sequence-deleted construct sNL was inhibited  
(~30% of wt sBM25A). To measure the efficiency of the deletion constructs sΔB, sΔP and s3'Δ55,  
RT-qPCR with (Figure 2C, left panel) or without (Figure 2C, right panel) previous head-to-tail ligation,  
primers MHV3'UTR6(−) and BCV23-40(+), or primers MHV3UTR-DR(−) and MHV3UTR-DR(+),  
were used respectively. As shown in Figure 2C, synthesis of the (−)-strand sgmRNA from the 
pseudoknot-deleted construct sΔP was inhibited (~50% of wt sBM25A). Surprisingly, (−)-strand 
sgmRNA synthesis from the sgmRNA construct with deletions of bulged stem-loop (sΔB) was not 
blocked. In contrast, the terminal 55-nt deletion in sgmRNA (s3'Δ55) significantly impaired the synthesis 
of its (−)-strand counterpart (~20% of wt sBM25A). To further determine whether the variation in  
the synthesis of (−)-strands among these constructs were due to changes in the number of (+)-strand 
templates resulting from replication, replication [interpreted as (+)-strand RNA synthesis] of wt 
sBM25A and sgmRNA mutants was analyzed by Northern blot assay from total cellular RNA 
extracted at 48 hpi of VP1. As shown in Figure S2, no accumulation of the (+)-strand reporter-containing 
sgmRNA was found, suggesting the efficiency of (−)-strand synthesis among these sgmRNA constructs 
was not affected by the number of (+)-strand templates due to replication. Since (1) the synthesis  
of the (−)-strand counterpart occurred under the similar experimental conditions as determined by the 
level of reporter-containing (+)-strand sgmRNA constructs, 18S rRNA, and M sgmRNA of helper 
virus BCoV at 8 hpt (VP0) with Northern blot assay (Figure 2D) and (2) these sgmRNA constructs 
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were dissemination-defective (Figure S2), these results suggest that the 5' leader sequence along with 
the 3'-terminal 55 nts and higher-order structure pseudoknot in sgmRNA are critical cis-acting elements 
required for (−)-strand sgmRNA synthesis. 
3.3. Deletion of Individual Stem-Loops within the Leader Sequence of sgmRNA 7 only Shows Minor 
Effects on (−)-Strand sgmRNA Synthesis 
Although it has been demonstrated for MHV DI RNA that the 5' UTR, including the leader sequence, 
does not affect the synthesis of (−)-strand sgmRNA [26], we found here in this study that the leader 
sequence was required for the efficient synthesis of BCoV (−)-strand sgmRNA 7 (Figure 2B). The leader 
sequence in sgmRNA 7 of BCoV forms two stem-loops [13]; however, their role in the (−)-strand 
sgmRNA synthesis remains to be determined. To further dissect the cis-acting elements within the leader 
sequence required for (−)-strand sgmRNA synthesis, we generated constructs sΔSL1 and sΔSL2 in 
which stem-loop I and stem-loop II, respectively, was deleted (Figure 3A) and performed RT-qPCR 
with the head-to-tail RNA ligation step using primers MHV3UTR-DR(−) and BCVN(+) because the 
primer BCV23-40(+) used for RT-qPCR in the above-described studies cannot anneal to the (−) strand 
of sNL and sΔSL1. RT-qPCR was also used without the head-to-tail RNA ligation step using primers 
MHV3UTR-DR(−) and MHV3UTR-DR(+) to measure the efficiency of (−)-strand sgmRNA synthesis. 
As shown in Figure 3B, with (left panel) or without (right panel) the step of head-to-tail RNA ligation, 
the efficiency of (−)-strand sgmRNA synthesis from either of sΔSL1 and sΔSL2 was only slightly 
decreased in comparison to that from wt sBM25A under the similar experimental conditions (Figure 3C), 
whereas (−)-strand sgmRNA synthesis was still inhibited from sNL, the construct in which the leader 
sequence was deleted. These results suggest stem-loop I or stem-loop II alone still supports efficient  
(−)-strand sgmRNA synthesis; however, (−)-strand sgmRNA synthesis is significantly inhibited when 
both structures are missing. 
Figure 2. Identification of the cis-acting elements within the 5' and 3' UTRs of sgmRNA 
that are required for (−)-strand sgmRNA synthesis. (A) Illustration of the constructs with 
deletions in the 5' UTR (construct sNL) and 3' UTR (constructs sΔB, sΔP, and s3'Δ55).  
SL: stem-loop; BSL: bulged stem-loop; PK: pseudoknot; HVR: hypervariable region.  
(B) The relative efficiency of (−)-strand sgmRNA synthesis, as measured by RT-qPCR 
with (left panel) or without (right panel) head-to-tail ligation. Left panel: Control A: total 
cellular RNA from mock-infected cells. Control B: total cellular RNA from BCoV-infected  
cells. Control C: total cellular RNA from sBM25A-transfected mock-infected cells. Control 
D: a mixture of BCoV-infected cellular RNA extracted at 8 hpt and 200 ng of sBM25A 
transcript. Right panel: Control A: total cellular RNA from mock-infected cells. Control B: 
total cellular RNA from BCoV-infected cells. Control C: total cellular RNA from 
sBM25A-transfected mock-infected cells. Control D: total cellular RNA from sNL -transfected 
mock-infected cells. (C) The relative efficiency of (−)-strand sgmRNA synthesis, as 
measured by RT-qPCR with (left panel) or without (right panel) head-to-tail ligation. Left 
panel: Control A: total cellular RNA from mock-infected cells. Control B: total cellular 
RNA from BCoV-infected cells. Control C: total cellular RNA from sBM25A-transfected 
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mock-infected cells. Control D: a mixture of BCoV-infected cellular RNA extracted at  
8 hpt and 200 ng of sBM25A transcript. Right panel: Control A: total cellular RNA from  
mock-infected cells. Control B: total cellular RNA from BCoV-infected cells. Control C: 
total cellular RNA from sBM25A-transfected mock-infected cells. Control D: total cellular 
RNA from sΔB-transfected mock-infected cells. Control E: total cellular RNA from  
sΔP-transfected mock-infected cells. Control F: total cellular RNA from s3'Δ55-transfected 
mock-infected cells. (D) Measurements of reporter-containing sgmRNA, 18S rRNA and M 
sgmRNA (from helper virus) at 8 hpt of VP0 by Northern blot assay. M sgmRNA rather 
than N sgmRNA was chosen to represent helper virus here and in the following figures 
because the reporter-containing (+)-strand sgmRNA and BCoV N sgmRNA (sgmRNA 7) 
migrated to the same position. The values (B) and (C) represent the mean ± SD of three 
individual experiments. ** p < 0.01, *** p < 0.001. 
 
Viruses 2014, 6 2949 
 
 
Figure 3. Identification of cis-acting elements within the leader sequence that are essential 
for (−)-strand sgmRNA synthesis. (A) Constructs with deletions in the leader sequence  
of wt sBM25A. sΔSL1: deletion of stem-loop I; sΔSL2: deletion of stem-loop II; sNL: 
deletion of the leader sequence. SL: stem-loop; BSL: bulged stem-loop; PK: pseudoknot; 
HVR: hypervariable region. (B) The relative efficiency of (−)-strand RNA synthesis between 
the constructs, as measured by RT-qPCR with (left panel) or without (right panel) head-to-tail 
ligation. Left panel: Control A: total cellular RNA from mock-infected cells. Control B:  
total cellular RNA from BCoV-infected cells. Control C: total cellular RNA from 
sBM25A-transfected mock-infected cells. Control D: a mixture of BCoV-infected cellular 
RNA extracted at 8 hpt and 200 ng of sBM25A transcript. Right panel: Control A: total 
cellular RNA from mock-infected cells. Control B: total cellular RNA from BCoV-infected 
cells. Control C: total cellular RNA from sBM25A-transfected mock-infected cells. 
Control D: total cellular RNA from sΔSL1-transfected mock-infected cells. Control E: total 
cellular RNA from sΔSL2-transfected mock-infected cells. Control F: total cellular RNA 
from sNL-transfected mock-infected cells. (C) Measurements of reporter-containing sgmRNA, 
18S rRNA and M sgmRNA (from helper virus) at 8 hpt of VP0 by Northern blot analysis. 
The values (B) represent the mean ± SD of three individual experiments. *** p<0.001. 
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Figure 3. Cont. 
 
3.4. The 3'-Terminal nts Positioned from −15 to −34 is Required for Efficient (−)-Strand  
sgmRNA Synthesis 
Using MHV DI RNA, it has been concluded that the 3'-terminal 55 nts are essential for (−)-strand 
DI RNA synthesis [26]. We also demonstrated in previous [32] and present (Figure 2C) studies that the 
3'-terminal 55 nts in BCoV DI RNA and sgmRNA 7, respectively, are required for (−)-strand RNA 
synthesis. To map the specific sequence within the 3'-terminal 55-nt region of sgmRNAs that is critical 
for synthesis of (−)-strand sgmRNA, a series of deletion mutants were constructed (Figure 4A) and 
tested using RT-qPCR. Constructs were tested with (Figure 4B, left panel) or without (Figure 4C, right 
panel) prior head-to-tail RNA ligation with primers MHV3UTR6(−) and BCV23-40(+), or primers 
MHV3UTR-DR(−) and MHV3UTR-DR(+), respectively. As shown in Figure 4B, under the similar 
experimental conditions (Figure 4C), deletion mutant s3'Δ15 in which the 3'-most 15 nts were deleted 
still maintained the ability to synthesize its (−)-strand counterpart, as did the mutants s3'Δ55–35  
and s3'Δ55–40; however, the (−)-strand sgmRNA synthesis in mutants s3'Δ55–30 and s3'Δ30–15 was 
significantly inhibited, suggesting that the sequence positioned from −15 to −34 within the 3'-terminal 
55 nts is a cis-acting element required for the efficient synthesis of (−)-strand sgmRNA. 
3.5. The 3'-Most Nucleotide Species of sgmRNA 7 Affects the Efficiency of (−)-Strand  
sgmRNA Synthesis 
The last nucleotide of the 3'UTR in all coronavirus genomes and subgenomes sequenced to date is 
cytosine. Therefore, this conserved nucleotide may play an important role during coronavirus infection. 
Since this nucleotide positions at the 3'-terminus of genome and subgenome, we speculated that it may 
be involved in (−)-strand RNA synthesis. To test whether this nucleotide correlates with the efficiency 
of (−)-strand sgmRNA synthesis, the cytosine was substituted with adenine, uracil, and guanine to create 
constructs sgmA’, sgmU’, and sgmG’, respectively (Figure 5A). As shown in Figure 5B, using RT-qPCR 
with (left panel) or without (right panel) the head-to-tail RNA ligation with primers MHV3UTR6(−) 
and BCV23-40(+) or primers MHV3UTR-DR(−) and MHV3UTR-DR(+), respectively, the efficiency of 
(−)-strand synthesis from construct sgmA’, sgmU’ and sgmG under the similar experimental conditions 
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(Figure 5C) was decreased in comparison with that from wt sBM25A. These results suggest that the 
nucleotide species at the 3'-most position is correlated to the efficiency of (−)-strand sgmRNA synthesis. 
Figure 4. Mapping the cis-acting elements within 3'-terminal 55 nts that are required for  
(−)-strand sgmRNA synthesis. (A) Upper panel: schematic diagram depicting the sgmRNA. 
The 3'-terminal 55 nts are indicated. Lower panel: constructs of sgmRNA with deletions 
within the 3'-terminal 55 nts. SL: stem-loop; BSL: bulged stem-loop; PK: pseudoknot; HVR: 
hypervariable region. (B) The relative efficiency of (−)-strand RNA synthesis between the 
constructs, as measured by RT-qPCR with (left panel) or without (right panel) head-to-tail 
ligation. Left panel: Control A: total cellular RNA from mock-infected cells. Control B: 
total cellular RNA from BCoV-infected cells. Control C: total cellular RNA from 
sBM25A-transfected mock-infected cells. Control D: a mixture of BCoV-infected cellular 
RNA extracted at 8 hpt and 200 ng of sBM25A transcript. Right panel: Control A: total 
cellular RNA from mock-infected cells. Control B: total cellular RNA from BCoV-infected 
cells. Controls C–H: total cellular RNA from mock-infected cells transfected with sBM25A, 
s3'Δ55–40, s3'Δ55–35, s3'Δ55–30, s3'Δ30–15 and s3'Δ15, respectively. (C) Measurements 
of reporter-containing sgmRNA, 18S rRNA and M sgmRNA (from helper virus) at 8 hpt of 
VP0 by Northern analysis. The values (B) represent the mean ± SD of three individual 
experiments. * p < 0.05, ** p < 0.01. 
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Figure 5. The effect of the 3'-most nt species on the synthesis of (−)-strand sgmRNA.  
(A) Upper panel: schematic diagram depicting the sgmRNA. Lower panel: constructs with 
nucleotide substitution at the 3'-most nt of sgmRNA. (B) The relative efficiency of (−)-strand 
RNA synthesis between the constructs, as measured by RT-qPCR with (left panel) or 
without (right panel) head-to-tail ligation. Left panel: Control A: total cellular RNA from 
mock-infected cells. Control B: total cellular RNA from BCoV-infected cells. Control C: 
total cellular RNA from sBM25A-transfected mock-infected cells. Control D: a mixture  
of BCoV-infected cellular RNA extracted at 8 hpt and sBM25A transcript. Right panel: 
Control A: total cellular RNA from mock-infected cells. Control B: total cellular RNA 
from BCoV-infected cells. Control C: total cellular RNA from sBM25A-transfected  
mock-infected cells. Control D: total cellular RNA from sgmA’-transfected mock-infected 
cells. Control E: total cellular RNA from sgmU’-transfected mock-infected cells. Control F: 
total cellular RNA from sgmG’-transfected mock-infected cells. (C) Measurements of 
reporter-containing sgmRNA, 18S rRNA and M sgmRNA (from helper virus) at 8 hpt  
of VP0 by Northern analysis. Values (B) represent the mean ± SD of three individual 
experiments. * p < 0.05, ** p < 0.01. 
 
4. Discussion 
The previously published study has shown that (+)-strand sgmRNA can function as a template  
for the synthesis of (−)-strand counterpart [14]; however, the efficiency of (−)-strand synthesis using  
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(+)-strand sgmRNA 7 as a template remains unknown. In the present study, we have demonstrated that 
the efficiency of (−)-strand sgmRNA synthesis from sgmRNA 7 is ~50% less than that from BCoV DI 
RNA (Figure 1D), a surrogate for the ~30 kb BCoV genome. The result that (+)-strand sgmRNAs still 
maintain the ability to synthesize their (−)-strand copies is not surprising since sgmRNA equips  
the complete secondary structures in 3' UTR required for the initiation of (−)-strand synthesis based on  
the secondary structure model proposed by Züst et al. [45] and thus the 5'-end genome-specific 412 nts 
which differentiate DI RNA from sgmRNA (Figure 1A) might function as an enhancer in the initiation 
of (−)-strand synthesis. Although the efficiency of (−)-strand synthesis from sgmRNA is impaired,  
the overwhelming abundance of total sgmRNAs in BCoV-infected cells (~6000 and ~20 molecules for 
sgmRNA and genome per cell, respectively) [41] may suggest that there are a number of (−)-strand 
sgmRNAs synthesized with (+)-strand sgmRNAs as templates, reinforcing the biological significance 
of (−)-strand sgmRNA synthesis using (+)-strand sgmRNAs as templates. Furthermore, the finding 
that (+)-strand sgmRNA with a transcription signal can be employed as a template to synthesize smaller 
sgmRNAs has also emphasized the additional function of coronavirus sgmRNAs [14]. As many of  
the cis-acting elements in the coronavirus genome required for replication have been identified in the  
past two decades [22–24,27,28,31,33–35,46–51], it is also important to examine the RNA elements on 
the (+)-strand sgmRNA that are required for the synthesis of its (−)-strand counterpart. In the present 
study, we identified the cis-acting elements on the (+)-strand sgmRNA that are essential for efficient  
(−)-strand sgmRNA synthesis, and these findings have expanded our knowledge of coronavirus replication. 
It appears that the main function of the BCoV DI RNA 5'-proximal 421 nts, which is missing in 
sgmRNA, is for (+)-strand DI RNA synthesis because (1) both DI RNA and sgmRNA are able to generate 
their (−)-strand counterparts and (2) only (+)-strand DI RNA can be synthesized from the template of 
DI RNA (−) strand. In addition, since the efficiency of (−)-strand sgmRNA synthesis from sgmRNA is 
~50% less than that from BCoV DI RNA (Figure 1D) and is ~3-fold higher than that from construct 
sNL in which both the leader sequence and 5'-proximal 421 nts are missing (Figure 2B), the efficiency 
of (−)-strand synthesis from BCoV DI RNA therefore is estimated to be ~6-fold higher than that from 
construct sNL. These results indicate that the 5'-terminal 498 nts of the coronavirus genome, including 
the leader sequence, are required for efficient (−)-strand RNA synthesis. This conclusion is different 
from a previously published work which suggested that the 5'-terminal sequence is not required for 
efficient (−)-strand RNA synthesis in MHV DI RNA using a ribonuclease protection assay [26].  
The reasons for the different findings may be largely associated with the structural components and  
the replication mechanism between the two DI RNAs and are explained as follows. (1) MHV DI RNA 
consists of both MHV 5' and 3' UTRs and a foreign CAT gene, but the components of BCoV DI RNA 
are all from the BCoV genome, including the BCoV 5' UTR, 3' UTR, part of the nsp 1 gene, and intact 
N gene. (2) It has been demonstrated that the replication of BCoV DI RNA is translation-dependent [52], 
indicating the BCoV DI RNA fusion protein and potential interaction between the fusion protein  
and structures on the DI RNA are important for replication, including (−)-strand DI RNA synthesis; 
however, cis-acting proteins are not required for the replication of MHV DI RNA [53]. It has been 
demonstrated, using a complete reverse genetic system, that SL I and SL II in the 5' UTR of MHV-A59 
genome are required for (−)-strand sgmRNA synthesis [47,48], whereas using BCoV sgmRNA 7 and 
RT-qPCR we have demonstrated in the present study that the deletion of either of the SLs in the 
context of sgmRNA 7 still supports (−)-strand sgmRNA synthesis (Figure 3B). We speculate that SL I 
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or SL II alone may still maintain part of secondary structure required for (−)-strand sgmRNA synthesis 
and that is why the efficiency of (−)-strand synthesis from either of the deletion constructs was  
only slightly impaired. However, once the entire secondary structure required for (−)-strand sgmRNA 
synthesis was missing, the synthesis of (−)-strand sgmRNA was significantly blocked as evidenced by 
the results from sNL (Figure 3B). Alternatively, regarding the cis-acting function for SL I and SL II in 
the context of subgenome and genome, these results may suggest that the individual SL is required for 
the template switching that is essential for the synthesis of (−)-strand sgmRNA from genome but the 
individual SL is not critical for the subsequent amplification of sgmRNA (−) strand using sgmRNA as a 
template. 
Based on the secondary structure model of MHV 3' UTR proposed by Züst et al. [45], two helical 
stems formed at the terminus of MHV 3' UTR are functionally important for the initiation of (−)-strand 
RNA synthesis. Subsequent analysis of the two stems by Liu et al. [54] with reverse genetic approaches 
suggests that the first stem (designated S3) in which nts 0 to −9 (0 indicates the 5'-most nt of the 
poly(A) tail and −9 indicates the ninth nt counted from poly(A) tail) are base-paired with loop 1 of the 
pseudoknot stem is required for virus viability; however, disruptions in the second stem (designated S4) 
in which nts −18 to −29 are base-paired with nts downstream of the pseudoknot stem 2 generate both 
viable and lethal mutants. Interestingly, in the present study the deletion mutant s3'Δ15, in which the 
3'-most 15 nts were deleted, still maintained the ability to synthesize its (−)-strand counterpart and 
therefore does not seem to support the Züst model. However, folding of this deleted mutant by Mfold 
algorithm revealed that the partial S3 and entire S4 are still maintained although the base-paired 
sequence in S4 is altered. Since the secondary structures of S3 and S4 are not impaired dramatically, 
this may explain why the mutant s3'Δ15 still supports the (−)-strand sgmRNA synthesis. In contrast, 
folding of the mutants s3'Δ30–15 and pseudoknot-deleted sΔP by Mfold algorithm showed that  
the structures of both S3 and S4 are disrupted and this may account for the significant inhibition of  
(−)-strand sgmRNA synthesis for these mutants. Therefore, regarding the secondary structures of the 
two helical stems S3 and S4 in the (−)-strand sgmRNA synthesis, the results in the present study are 
consistent with the conclusions by Liu et al. [54] and support the model proposed by Züst et al. [45]. 
It has been demonstrated that the 3'-most nucleotide species in BCoV DI RNA affects the 
efficiency of (−)-strand RNA synthesis [32]. The same results were obtained for sgmRNA 7 in the 
present study (Figure 5). However, (−)-strand RNA synthesis from mutant s3'Δ15 was maintained even 
though the 3'-most 15 nucleotides had been deleted. Upon examination it was learned the 3'-most 
nucleotide in mutant s3'Δ15 (cytosine) was the same as that on wt sBM25A. Since this nucleotide is the 
same, and since the secondary structures of S3 and S4 are not seriously impaired as discussed above, these 
features may explain why this mutant still maintained the ability to synthesize its (−)-strand counterpart. 
The terminal structures, including the 5'-terminal leader sequence and 3'-terminal 55 nts, on sgmRNA 
apparently play critical roles with regard to (−)-strand sgmRNA synthesis. It is logical that the initiation 
of (−)-strand sgmRNA synthesis is triggered from the 3' terminus of sgmRNA and that mutations  
in the 3'-terminal region may be detrimental to the synthesis of (−)-strand sgmRNA. However, the 
question remains as to how the sgmRNA 5'-terminal structures affect (−)-strand sgmRNA synthesis, as 
deletion of the 5' leader sequence impaired the synthesis of (−)-strand sgmRNA in this study. Since the 
interactions between the 5' and 3' termini of the virus genome have been suggested to be required for 
the initiation of replication in RNA viruses [2,9,12,46,55–61], including coronaviruses [2,9,12,46,57], 
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and both the 5'-terminal leader sequence and 3'-terminal 55-nt sequence in the context of (+)-strand 
sgmRNA are required for the (−)-strand sgmRNA synthesis, we speculate that the interactions between 
the 5' and 3' termini of (+)-strand sgmRNA may explain why the 5'-terminal leader sequence is critical  
for the synthesis of (−)-strand sgmRNA. With this interpretation, we would like to note that since other  
5'-terminal structures between BCoV DI RNA and sgmRNA differ (Figure 1A), the cis-acting 
requirements within the 5' and 3' termini and the nature of the assembled replication complexes leading 
to the initiation of (−)-strand RNA synthesis probably also vary between the two RNA species. 
Therefore, this variation in structure may explain why nts −55 to −35 and the last 15 nts within the  
3'-terminal 55-nt sequence are required for efficient (−)-strand BCoV DI RNA synthesis [32], but are 
dispensable for (−)-strand sgmRNA synthesis in the present study (Figure 4). 
In this study, we systematically examined the cis-acting elements on sgmRNA and found that  
the 5'- and 3'-terminal sequences on sgmRNA 7 harbor cis-acting elements essential for efficient  
(−)-strand sgmRNA synthesis in BCoV. These findings have extended our knowledge of coronavirus 
replication. Furthermore, the reasons for the various observations discussed above regarding the 
requirements of 5'- and 3'-terminal cis-acting elements for the synthesis of (−)-strand RNA from 
genomic RNA and sgmRNA remain unclear; however, we speculate that the different experimental 
approaches may be largely responsible for the different outcomes. Therefore, further studies with similar 
systems are required in order to explain the various results. 
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